-
Mylan launches generic drug for kidney transplant patients
PITTSBURGH — Mylan has launched a generic drug for preventing rejection of transplanted organs, the company said Thursday.
The generic drug maker announced the launch of mycophenolic acid delayed-release tablets in the 180-mg and 360-mg strengths. The drug is a generic version of Novartis' Myfortic. As the first company to file a completed regulatory approval application for the generic, Mylan is entitled to 180 days in which to compete exclusively against Novartis' product before the Food and Drug Administration can approve additional generic versions.
-
Sparkling Ice announces new offerings
PRESTON, Wash. — Sparkling Ice, part of the TalkingRain portfolio of beverages, will expand its line of zero-calorie sparkling waters with the addition of two new flavors. Starting this month, consumers will get to indulge in Cherry Limeade and Strawberry Watermelon.
Sparkling Ice Cherry Limeade mingles the sweetness of cherries with the tanginess of lime to provide a bold flavor, while Strawberry Watermelon joins two summertime favorites for a refreshment that can be enjoyed year-round.